Grants8

Search for grants with us!

Keywords

You can filter by below criteria

Grants

Grants you might be eligible for

Grant Information Key Details Eligibility & Funding

Elucidating Immunometabolic Responses to HIV Infection that Increase TB or HBV Risk (R21 Clinical Trial Not Allowed)

PAR-25-316

Programme: NIH Grants

GRANT OVERVIEW

  • Elucidating Immunometabolic Responses to HIV Infection that Increase TB or HBV Risk (R21 Clinical Trial Not Allowed)
  • National Institutes of Health (NIH)

ELIGIBILITY CRITERIA

  • Eligible organization types include higher education institutions, nonprofits, for-profit organizations, small businesses, local and state governments, and federal agencies.
  • Specific qualifications include being a public or private institution, and certain nonprofits may require 501(c)(3) status.

Funding

Up to 275000.00 USD

Eligible Participants

EDU NGO PUBLIC ENTERPRISE SME OTHER

Deadline

Jan. 7, 2028, 10 p.m.

Details

Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

RFA-CA-25-001

Programme: NIH Grants

Grant Overview

  • Funding Organization: National Institutes of Health (NIH)
  • Total Funding Amount: Estimated at $150,000 per year

Eligibility Criteria

  • Eligible organization types include higher education institutions, nonprofits, for-profit organizations, small businesses, local governments, state governments, and tribal governments.
  • Non-domestic (non-U.S.) entities are eligible to apply.

Funding

Up to 150000.00 USD

Eligible Participants

UNIVERSITY NGO ENTERPRISE PUBLIC OTHER

Deadline

Oct. 3, 2025, 10 p.m.

Details

New Investigator Gateway Awards for Collaborative T1D Research (R03 Clinical Trial Not Allowed)

RFA-DK-26-009

Programme: NIH Grants

GRANT OVERVIEW

  • New Investigator Gateway Awards for Collaborative T1D Research
  • National Institutes of Health (NIH)

ELIGIBILITY CRITERIA

  • Eligible organization types include higher education institutions, nonprofits, for-profit organizations, and government entities.
  • Non-domestic entities (foreign organizations) are not eligible to apply.

Funding

Up to 100000.00 USD

Eligible Participants

EDU NGO PUBLIC ENTERPRISE OTHER

Deadline

March 6, 2026, 10 p.m.

Details

Interventions to Reduce Sleep Health Disparities (R01 - Clinical Trials Optional)

PAR-24-330

Programme: National Institutes of Health (NIH)

GRANT OVERVIEW

  • Interventions to Reduce Sleep Health Disparities (R01 - Clinical Trials Optional)
  • National Institutes of Health (NIH)

ELIGIBILITY CRITERIA

  • Eligible organization types include higher education institutions, nonprofits, for-profit organizations, local and state governments, and tribal governments.
  • Non-domestic (non-U.S.) entities are not eligible to apply.

Funding

Up to None USD

Eligible Participants

EDU NGO PUBLIC ENTERPRISE OTHER

Deadline

Sept. 7, 2027, 9 p.m.

Details

Supporting Talented Early Career Researchers in Genomics (R01 Clinical Trial Optional)

RFA-HG-25-009

Programme: NIH Grants

GRANT OVERVIEW

  • Supporting Talented Early Career Researchers in Genomics (R01 Clinical Trial Optional)
  • National Institutes of Health (NIH)

ELIGIBILITY CRITERIA

  • Eligible organization types include higher education institutions, nonprofits, for-profit organizations, small businesses, local governments, state governments, county governments, city or township governments, special district governments, and Indian/Native American tribal governments.
  • Non-domestic (non-U.S.) entities are not eligible to apply.

Funding

Up to 400000.00 USD

Eligible Participants

UNIVERSITY NGO PUBLIC ENTERPRISE SME

Deadline

Feb. 26, 2027, 10 p.m.

Details

Role of Defective Proviruses in HIV Persistence (R01 Clinical Trial Not Allowed)

PAR-25-330

Programme: NIH Grants

GRANT OVERVIEW

  • Role of Defective Proviruses in HIV Persistence (R01 Clinical Trial Not Allowed)
  • National Institutes of Health (NIH)

ELIGIBILITY CRITERIA

  • Eligible organization types include higher education institutions, nonprofits, for-profit organizations, local governments, state governments, and tribal governments.
  • Nonprofits with and without 501(c)(3) IRS status are eligible.

Funding

Up to 500000.00 USD

Eligible Participants

EDU NGO ENTERPRISE PUBLIC OTHER

Deadline

Jan. 7, 2028, 10 p.m.

Details

Collaborative Research Using Biosamples and/or Data from Type 1 Diabetes Clinical Studies (R01 - Clinical Trial Not Allowed)

RFA-DK-26-007

Programme: NIH Grants

GRANT OVERVIEW

  • Collaborative Research Using Biosamples and/or Data from Type 1 Diabetes Clinical Studies (R01 - Clinical Trial Not Allowed)
  • National Institutes of Health (NIH)

ELIGIBILITY CRITERIA

  • Eligible organization types include higher education institutions, nonprofits, for-profit organizations, local and state governments, and tribal governments.
  • Non-domestic (non-U.S.) entities are also eligible.

Funding

Up to 1200000.00 USD

Eligible Participants

EDU NGO ENTERPRISE PUBLIC OTHER

Deadline

March 8, 2026, 10 p.m.

Details

National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U19 Clinical Trial Optional)

PAR-25-353

Programme: NIH Mental Health Research Grants

Grant Overview

  • Funding Organization: National Institutes of Health (NIH)
  • Total Funding Amount: Not specified

Eligibility Criteria

  • Eligible organization types include higher education institutions, nonprofits, for-profit organizations, local and state governments, and federal agencies.
  • Specific qualifications include having the necessary skills, knowledge, and resources to carry out the proposed research.

Funding

Up to None USD

Eligible Participants

EDU NGO ENTERPRISE PUBLIC OTHER

Deadline

Oct. 25, 2027, 9 p.m.

Details

Advancing HIV/AIDS Research within the Mission of the NIDCD (R21 Clinical Trial Optional)

PAR-25-318

Programme: National Institutes of Health (NIH)

GRANT OVERVIEW

  • Advancing HIV/AIDS Research within the Mission of the NIDCD (R21 Clinical Trial Optional)
  • National Institutes of Health (NIH)

ELIGIBILITY CRITERIA

  • Eligible organization types include higher education institutions, nonprofits, small businesses, local and state governments, and tribal governments.
  • Non-domestic (non-U.S.) entities are also eligible to apply.

Funding

Up to 275000.00 USD

Eligible Participants

EDU NGO SME PUBLIC OTHER

Deadline

Jan. 7, 2028, 10 p.m.

Details

Joint NINDS/NIMH Exploratory Neuroscience Research Grant (R21 Clinical Trial Not Allowed)

PA-25-150

Programme: NIH Grants

GRANT OVERVIEW

  • Joint NINDS/NIMH Exploratory Neuroscience Research Grant
  • National Institutes of Health (NIH)

ELIGIBILITY CRITERIA

  • Eligible organization types include higher education institutions, nonprofits, for-profit organizations, local governments, state governments, and tribal governments.
  • Nonprofits with and without 501(c)(3) IRS status are eligible.

Funding

Up to 275000.00 USD

Eligible Participants

EDU NGO ENTERPRISE PUBLIC OTHER

Deadline

Jan. 7, 2028, 10 p.m.

Details

Ruth L. Kirschstein National Research Service Award (NRSA) Short-Term Institutional Research Training Grant (Parent T35)

PA-25-280

Programme: NIH Grants

GRANT OVERVIEW

  • Ruth L. Kirschstein National Research Service Award (NRSA) Short-Term Institutional Research Training Grant (Parent T35)
  • National Institutes of Health (NIH)

ELIGIBILITY CRITERIA

  • Eligible organization types include higher education institutions, nonprofits, local governments, and federal agencies.
  • Non-domestic entities (foreign organizations) are not eligible to apply.

Funding

Up to None USD

Eligible Participants

EDU NGO PUBLIC OTHER

Deadline

May 7, 2028, 9 p.m.

Details

Planning for Product Development Strategy (R34 Clinical Trial Not Allowed)

PAR-25-099

Programme: NIH Grants

GRANT OVERVIEW

  • Planning for Product Development Strategy (R34 Clinical Trial Not Allowed)
  • National Institutes of Health (NIH)

ELIGIBILITY CRITERIA

  • Eligible organization types include higher education institutions, nonprofits, for-profit organizations, and tribal governments.
  • Specific qualifications include being a public or state-controlled institution, private institution, or nonprofit with or without 501(c)(3) status.

Funding

Up to 225000.00 USD

Eligible Participants

PUBLIC NGO ENTERPRISE RESEARCH OTHER

Deadline

Dec. 4, 2026, 10 p.m.

Details

Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

RFA-CA-25-002

Programme: Innovative Molecular Analysis Technologies (IMAT) Program

GRANT OVERVIEW

  • RFA-CA-25-002
  • National Institutes of Health (NIH)

ELIGIBILITY CRITERIA

  • Eligible organization types include higher education institutions, nonprofits, for-profit organizations, local and state governments, and tribal governments.
  • Non-domestic (non-U.S.) entities are also eligible to apply.

Funding

Up to 300000.00 USD

Eligible Participants

EDU NGO ENTERPRISE SME PUBLIC OTHER

Deadline

Oct. 3, 2025, 10 p.m.

Details

Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required)

PAR-25-029

Programme: National Institutes of Health

GRANT OVERVIEW

  • Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required)
  • National Institutes of Health (NIH)

ELIGIBILITY CRITERIA

  • Eligible organization types include higher education institutions, nonprofits, for-profit organizations, local/state/county governments, and tribal governments.
  • Foreign organizations are also eligible to apply.

Funding

Up to None USD

Eligible Participants

EDU NGO PUBLIC ENTERPRISE OTHER

Deadline

Sept. 11, 2025, 10 p.m.

Details

F25AS00165 Partners for Fish and Wildlife FY25

F25AS00165

Programme: Partners for Fish and Wildlife

Grant Overview

  • Grant name: Partners for Fish and Wildlife FY25
  • Funding organization: U.S. Fish and Wildlife Service

Eligibility Criteria

  • Eligible organization types: Individuals, nonprofits (501(c)(3) and non-501(c)(3)), tribal governments, state and local governments, private institutions of higher education, small businesses.
  • Specific qualifications: Nonprofits must provide proof of 501(c)(3) status.

Funding

Up to 750000.00 USD

Eligible Participants

INDIVIDUAL NGO PUBLIC SME OTHER

Deadline

Oct. 1, 2025, 3:59 a.m.

Details

Interventions on Health and Healthcare Disparities on Non-Communicable and Chronic Diseases in Latin America: Improving Health Outcomes Across the Hemisphere (R01 - Clinical Trial Required)

PAR-25-342

Programme: NIH Grants

Grant Overview

  • Interventions on Health and Healthcare Disparities on Non-Communicable and Chronic Diseases in Latin America: Improving Health Outcomes Across the Hemisphere (R01 - Clinical Trial Required)
  • National Institutes of Health (NIH)

Eligibility Criteria

  • Eligible organizations include higher education institutions, nonprofits, for-profit organizations, local and state governments, and tribal governments.
  • Non-domestic (non-U.S.) entities are not eligible to apply.

Funding

Up to None USD

Eligible Participants

EDU NGO ENTERPRISE PUBLIC OTHER

Deadline

May 7, 2027, 9 p.m.

Details

NIDDK Centers for Diabetes Translation Research (P30 Clinical Trial Optional)

RFA-DK-26-001

Programme: NIDDK

GRANT OVERVIEW

  • NIDDK Centers for Diabetes Translation Research
  • National Institutes of Health (NIH)

ELIGIBILITY CRITERIA

  • Eligible organization types include higher education institutions, nonprofits, for-profit organizations, local/state/federal governments, and tribal governments.
  • Non-domestic (non-U.S.) entities are not eligible to apply.

Funding

Up to 400.00 USD

Eligible Participants

UNIVERSITY NGO PUBLIC ENTERPRISE SME OTHER

Deadline

June 10, 2025, 10 p.m.

Details

Behavioral and Integrative Treatment Development Program (R34 Clinical Trial Optional)

PAR-24-300

Programme: National Institutes of Health (NIH)

GRANT OVERVIEW

  • Behavioral and Integrative Treatment Development Program (R34 Clinical Trial Optional)
  • National Institutes of Health (NIH)

ELIGIBILITY CRITERIA

  • Eligible organization types include higher education institutions, nonprofits, for-profit organizations, local and state governments, and tribal governments.
  • Nonprofits must have or not have 501(c)(3) status with the IRS.

Funding

Up to 450000.00 USD

Eligible Participants

PUBLIC NGO SME OTHER

Deadline

May 7, 2025, 9 p.m.

Details

Time-Sensitive Evaluation of Policies Affecting Health Behaviors and Chronic Disease Risk (R01-Clinical Trial Not Allowed)

PAR-25-312

Programme: NIH Grants

GRANT OVERVIEW

  • Time-Sensitive Evaluation of Policies Affecting Health Behaviors and Chronic Disease Risk (R01-Clinical Trial Not Allowed)
  • National Institutes of Health (NIH)

ELIGIBILITY CRITERIA

  • Eligible organization types include higher education institutions, nonprofits, for-profit organizations, local and state governments, and tribal governments.
  • Non-domestic entities (foreign organizations) are not eligible to apply.

Funding

Up to None USD

Eligible Participants

PUBLIC NGO EDU ENTERPRISE OTHER

Deadline

Jan. 11, 2028, 10 p.m.

Details

NIAMS Clinical Trial Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)

PAR-25-141

Programme: NIH Grants

Grant Overview

  • Funding Organization: National Institutes of Health (NIH)
  • Total Funding Amount: Not specified

Eligibility Criteria

  • Eligible organization types include higher education institutions, nonprofits, for-profit organizations, local and state governments, and tribal governments.
  • Non-domestic (non-U.S.) entities are not eligible to apply.

Funding

Up to None USD

Eligible Participants

EDU NGO ENTERPRISE PUBLIC OTHER

Deadline

March 4, 2027, 10 p.m.

Details

789 results. Page 3 of 40.